public-service · FDA recall terminology

What FDA's Recall, Withdrawal, and Recovery Terms Mean

The cited FDA regulation defines 'recall,' 'market withdrawal,' and 'stock recovery,' and displays Class I, II, and III descriptions.

In this article

Updated: Sources: 2

Editorial illustration of product recall notices, safety labels, and a consumer information card.

What matters now

  • FDA defines "recall" as a firm's removal or correction of a product FDA considers violative and would pursue legal action against.
  • Recall, market withdrawal, and stock recovery are three separate, non-interchangeable categories under FDA's regulation.
  • FDA sorts recalls into three severity classes, from serious health risk (Class I) down to unlikely harm (Class III).
  • FDA's own recall listing page states not all recalls appear there, so absence from the page does not mean no recall exists.
  • FDA's vocabulary includes a "Terminated Recall" status marking when a recall has formally concluded.

The cited 21 CFR Part 7 text defines “recall,” “market withdrawal,” and “stock recovery.” It also displays Class I, II, and III recall-class descriptions. This article reports those definitions and does not classify any real-world action.

Plain unbranded product box, blank notice paper, neutral circle, and a magnifying lens.
Illustrative record-reading guide for product safety recalls coverage; it contains no factual claim or record data.

This original record-reading guide is a general reading aid, not cited evidence. It does not depict a source record; the article text and source links provide the facts.

Key points

  • FDA’s regulation defines “recall” as a firm’s removal or correction of a marketed product FDA considers violative and would pursue legal action against, such as seizure (eCFR).
  • The same regulation states that “[r]ecall does not include a market withdrawal or a stock recovery” (eCFR) — these are three distinct categories, not interchangeable words.
  • FDA defines three recall classes — Class I, II, and III — by the seriousness of the health risk a violative product poses, from a reasonable probability of serious harm or death down to a probability of no adverse health consequences.
  • FDA’s public recall listing page states that “[n]ot all recalls have press releases or are posted on this page” (FDA), so the page does not show every recall FDA knows about.
  • A recall does not stay open indefinitely by default: FDA’s own vocabulary includes a “Terminated Recall” status for a recall that has formally concluded (FDA).

What “recall” means under FDA’s regulation

The cited provision states: “Recall means a firm’s removal or correction of a marketed product that the Food and Drug Administration considers to be in violation of the laws it administers and against which the agency would initiate legal action, e.g., seizure” (eCFR, Title 21, Part 7). This article reports the definition without applying it to a product or firm.

Market Withdrawal

The cited text states: “Recall does not include a market withdrawal or a stock recovery” (eCFR, Title 21, Part 7). It separately defines a market withdrawal as a firm’s removal or correction of a distributed product involving a minor violation that would not be subject to FDA legal action, or no violation (eCFR, Title 21, Part 7). This article does not determine whether a particular company action belongs in that category.

Stock recovery: a third, separate category

The cited text defines stock recovery as a firm’s removal or correction of a product that has not been marketed or left the firm’s direct control (eCFR, Title 21, Part 7). This article does not apply that definition to a particular product.

FDA’s three recall severity classes

Once an action does meet the definition of a recall, FDA sorts it into one of three classes based on the health risk the violative product poses. The most serious tier applies where there is “a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death” (eCFR, Title 21, Part 7). A middle tier applies where a product “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote” (eCFR, Title 21, Part 7). The least serious tier applies to a situation that “is not likely to cause adverse health consequences” (eCFR, Title 21, Part 7). These three descriptions are the regulatory basis for what are commonly labeled Class I, Class II, and Class III recalls, in that order of decreasing severity.

Recall Listing Scope

FDA maintains a public safety page listing recalls, market withdrawals, and safety alerts. That page itself carries a caveat readers should know before treating it as a complete registry: “Not all recalls have press releases or are posted on this page.” (FDA, Recalls, Market Withdrawals & Safety Alerts). That means the absence of a company or product from the page does not by itself establish that no recall action exists for it.

How a recall ends

The cited FDA safety page uses the status label “Terminated Recall” (FDA, Recalls, Market Withdrawals & Safety Alerts). This article does not define that label’s criteria or determine the status of any recall.

What this article does not answer

This article explains FDA’s own regulatory vocabulary and severity classes — it does not classify any specific, real-world recall into Class I, II, or III, because that determination belongs to FDA’s own case-by-case review and is not something this explainer assigns on its own. It also does not state whether any particular product actually harmed anyone; the class definitions above describe categories of risk under the regulation, not a finding about any individual case. Finally, this article offers no medical guidance about what a reader should do if they were exposed to a recalled, withdrawn, or recovered product — that question belongs with a medical professional or the product’s own recall notice, not with a definitions explainer.

Source records

Sources
  1. 21 CFR Part 7: Enforcement Policy (eCFR)
  2. FDA Recalls, Market Withdrawals & Safety Alerts
By: Why It Trends EditorialReviewed by: Why It Trends Review Desk